CL2011000378A1 - Uso de edta asociado a trometamina o sales de edta oftalmologicamente aceptables asociadas a trometamina, y/o uno o mas fotointensificadores escogidos entre; amarillo de acridina, amarillo de quinidina, azul de metileno, eritrosina; composicion oftalmologica. - Google Patents

Uso de edta asociado a trometamina o sales de edta oftalmologicamente aceptables asociadas a trometamina, y/o uno o mas fotointensificadores escogidos entre; amarillo de acridina, amarillo de quinidina, azul de metileno, eritrosina; composicion oftalmologica.

Info

Publication number
CL2011000378A1
CL2011000378A1 CL2011000378A CL2011000378A CL2011000378A1 CL 2011000378 A1 CL2011000378 A1 CL 2011000378A1 CL 2011000378 A CL2011000378 A CL 2011000378A CL 2011000378 A CL2011000378 A CL 2011000378A CL 2011000378 A1 CL2011000378 A1 CL 2011000378A1
Authority
CL
Chile
Prior art keywords
tromethamine
yellow
edta
quinidine
chosen
Prior art date
Application number
CL2011000378A
Other languages
English (en)
Inventor
Marcello Stagni
Edoardo Stagni
Massimo Filippello
Giovanni Cavallo
Eugenio Sodo
Original Assignee
Sooft Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000378(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sooft Italia Spa filed Critical Sooft Italia Spa
Publication of CL2011000378A1 publication Critical patent/CL2011000378A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE EDTA ASOCIADO A TROMETAMINA O SALES DE EDTA OFTALMOLÓGICAMENTE ACEPTABLES ASOCIADAS A TROMETAMINA, Y/O UNO O MAS FOTO-INTENSIFICADORES ESCOGIDOS ENTRE LOS TINTES: AMARILLO DE ACRIDINA, AMARILLO DE QUINIDINA, AZUL DE METILENO, ERITROSINA, QUE SIRVE PARA LA PREPARACIÓN DE COMPOSICIONES OFTÁLMICAS EN LA RETICULACIÓN DE LA CÓRNEA PARA FAVORECER EL PASO DE LA COMPOSICIÓN OFTÁLMICA AL ESTROMA A TRAVÉS DEL EPITELIO CORNEAL, DONDE LA COMPOSICIÓN COMPRENDE RIBOFLAVINA O FOSFATO DE RIBOFLAVINA; Y COMPOSICIÓN PORQUE COMPRENDE EDTA ASOCIADO A LA TROMETAMINA, UNA SAL DE EDTA OFTALMOLÓGICAMENTE ACEPTABLE ASOCIADA A LA TROMETAMINA, ESTÁ PRESENTE CON UNO O MÁS FOTO-INTENSIFICADORES Y RIBOFLAVINA.
CL2011000378A 2008-08-28 2011-02-22 Uso de edta asociado a trometamina o sales de edta oftalmologicamente aceptables asociadas a trometamina, y/o uno o mas fotointensificadores escogidos entre; amarillo de acridina, amarillo de quinidina, azul de metileno, eritrosina; composicion oftalmologica. CL2011000378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2008A000472A IT1393402B1 (it) 2008-08-28 2008-08-28 Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali

Publications (1)

Publication Number Publication Date
CL2011000378A1 true CL2011000378A1 (es) 2011-06-10

Family

ID=40679354

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000378A CL2011000378A1 (es) 2008-08-28 2011-02-22 Uso de edta asociado a trometamina o sales de edta oftalmologicamente aceptables asociadas a trometamina, y/o uno o mas fotointensificadores escogidos entre; amarillo de acridina, amarillo de quinidina, azul de metileno, eritrosina; composicion oftalmologica.

Country Status (18)

Country Link
US (1) US20110152219A1 (es)
EP (1) EP2323642B1 (es)
JP (1) JP2012500844A (es)
KR (1) KR20110046567A (es)
CN (1) CN102164592B (es)
AU (1) AU2009286285B2 (es)
BR (1) BRPI0910368B8 (es)
CL (1) CL2011000378A1 (es)
DK (1) DK2323642T3 (es)
EA (2) EA023607B1 (es)
ES (1) ES2460578T3 (es)
IL (1) IL211448A (es)
IT (1) IT1393402B1 (es)
MX (2) MX358176B (es)
PE (1) PE20110287A1 (es)
PL (1) PL2323642T3 (es)
PT (1) PT2323642E (es)
WO (1) WO2010023705A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2227197A4 (en) 2007-12-05 2011-06-22 Avedro Inc EYE THERAPY SYSTEM
US8366689B2 (en) 2008-09-30 2013-02-05 Avedro, Inc. Method for making structural changes in corneal fibrils
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
US9707126B2 (en) 2009-10-21 2017-07-18 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
JP6377906B2 (ja) 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼治療を適用およびモニターするためのシステム
US20120289886A1 (en) * 2010-04-13 2012-11-15 Avedro, Inc. Controlled application of cross-linking agent
US20110280763A1 (en) * 2010-05-17 2011-11-17 Abbott Medical Optics Inc. Light-activated disinfection system
IT1400982B1 (it) 2010-07-05 2013-07-05 Pinelli Collirio osmotico trans-epiteliale per la cura del cheratocono.
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US20130310732A1 (en) * 2011-01-12 2013-11-21 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
KR101669715B1 (ko) 2011-01-12 2016-10-27 수프트 이탈리아 에스피에이 원추각막 치료용 이온이동법에 의한 리보플라빈의 각막 전달 장치 및 방법
US9044308B2 (en) 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
US9020580B2 (en) 2011-06-02 2015-04-28 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
ITRM20110560A1 (it) * 2011-10-25 2013-04-26 Sooft Italia Spa Migliorata composizione di cross-linking per il trattamento del cheratocono mediante iontoforesi
RU2481809C1 (ru) * 2011-12-21 2013-05-20 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения кератэктазии после лазик
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
EP2830637A4 (en) 2012-03-29 2016-03-16 Cxl Ophthalmics Llc COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES RELATED TO OXIDATIVE STRESS
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
RU2487691C1 (ru) * 2012-04-12 2013-07-20 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения кератоконуса
AU2013375414B2 (en) * 2013-01-28 2016-11-03 Alcon Inc. Apparatus for corneal crosslinking
EP3858356A3 (en) * 2013-05-19 2021-12-01 Avedro, Inc. Systems, methods, and compositions for cross-linking
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
RU2542799C1 (ru) * 2013-10-29 2015-02-27 Игорь Борисович Медведев Способ лечения кератоконуса роговицы
US9931199B2 (en) * 2014-05-05 2018-04-03 Roberto Gustavo ALBERTAZZI Methods and apparatus for treating keratoconus
US11648261B2 (en) 2014-05-12 2023-05-16 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
US10278920B1 (en) 2014-05-12 2019-05-07 Gholam A. Peyman Drug delivery implant and a method using the same
US10881503B2 (en) 2014-05-12 2021-01-05 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US9427355B1 (en) * 2014-05-12 2016-08-30 Gholam A. Peyman Corneal transplantation with a cross-linked cornea
US9744029B1 (en) 2014-05-12 2017-08-29 Gholam A. Peyman Method of preventing capsular opacification and fibrosis utilizing an accommodative intraocular lens implant
US10925889B2 (en) 2014-05-12 2021-02-23 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
US11259914B2 (en) 2014-05-12 2022-03-01 Gholam A. Peyman Molding or 3-D printing of a synthetic refractive corneal lenslet
US11045352B2 (en) 2014-05-12 2021-06-29 Gholam A. Peyman Methods for treatment of dry eye and other acute or chronic inflammatory processes
US9937033B1 (en) 2014-05-12 2018-04-10 Gholam A. Peyman Corneal lenslet implantation with a cross-linked cornea
US11666777B2 (en) 2014-05-12 2023-06-06 Gholam A. Peyman Photodynamic therapy technique for preventing damage to the fovea of the eye or another body portion of a patient
US10583221B2 (en) 2014-05-12 2020-03-10 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US10709546B2 (en) 2014-05-12 2020-07-14 Gholam A. Peyman Intracorneal lens implantation with a cross-linked cornea
US10195081B1 (en) 2014-05-12 2019-02-05 Gholam A. Peyman Method of prevention of capsular opacification and fibrosis after cataract extraction and/or prevention of fibrosis around a shunt or stent after glaucoma surgery
US11565023B2 (en) 2014-05-12 2023-01-31 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
US10206569B1 (en) 2014-05-12 2019-02-19 Gholam A. Peyman Corneal intraocular pressure sensor and a surgical method using the same
US11338059B2 (en) 2014-05-12 2022-05-24 Gholam A. Peyman Method of corneal and scleral inlay crosslinking and preservation
US10314690B1 (en) 2014-05-12 2019-06-11 Gholam A. Peyman Method of corneal transplantation or corneal inlay implantation with cross-linking
KR102545628B1 (ko) 2014-10-27 2023-06-20 아베드로 인코퍼레이티드 눈의 교차-결합 처리를 위한 시스템 및 방법
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
HUE040373T2 (hu) 2015-04-29 2019-03-28 Sooft Italia S P A Kollagén-rostok javított térhálósító szerei cornealis ectasia kezelésében való alkalmazásra
WO2016191342A1 (en) 2015-05-22 2016-12-01 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
US11207410B2 (en) 2015-07-21 2021-12-28 Avedro, Inc. Systems and methods for treatments of an eye with a photosensitizer
CN105256059B (zh) * 2015-11-20 2019-01-18 山东省眼科研究所 Tuba3d基因在制备圆锥角膜诊断制品中的应用
ITUB20160237A1 (it) * 2016-01-26 2017-07-26 Vision Engineering Italy Soc A Responsabilita Limitata Apparato di controllo del dosaggio di un agente cromoforo in un tessuto corneale e procedimento per dosare un agente cromoforo in un tessuto corneale
WO2017180851A1 (en) 2016-04-13 2017-10-19 Avedro, Inc. Systems and methods for delivering drugs to an eye
WO2018156593A1 (en) * 2017-02-21 2018-08-30 Avedro, Inc. Formulations for eye treatments
US11766356B2 (en) 2018-03-08 2023-09-26 Avedro, Inc. Micro-devices for treatment of an eye
US11707518B2 (en) 2019-04-28 2023-07-25 Gholam A. Peyman Method of treating, reducing, or alleviating a medical condition in a patient
CA3147045A1 (en) 2019-08-06 2021-02-11 Desmond C. Adler Photoactivation systems and methods for corneal cross-linking treatments
CN110314034B (zh) * 2019-08-08 2021-12-03 南京市第一医院 一种可实现个性治疗的角膜交联装置
US11458220B2 (en) 2020-11-12 2022-10-04 Singletto Inc. Microbial disinfection for personal protection equipment
CN115177729B (zh) * 2022-08-03 2023-09-26 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) 肾上腺素受体激动剂在制备圆锥角膜交联促渗剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
CN1200698C (zh) * 1998-03-09 2005-05-11 伊斯塔药品公司 角膜硬化剂在制备治疗眼睛屈光不正的药物中的用途
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
DE60143514D1 (de) * 2000-02-11 2011-01-05 Gen Hospital Corp Photochemische gewebeverbindung
AU2003297511B2 (en) * 2002-12-20 2010-01-21 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
ITRM20050443A1 (it) * 2005-08-12 2007-02-13 Opocrin Spa Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea.
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE

Also Published As

Publication number Publication date
EA023607B1 (ru) 2016-06-30
EP2323642B1 (en) 2014-02-19
MX2011002234A (es) 2011-04-05
IT1393402B1 (it) 2012-04-20
CN102164592B (zh) 2015-09-23
EA201100393A1 (ru) 2011-10-31
JP2012500844A (ja) 2012-01-12
AU2009286285B2 (en) 2015-03-26
EP2323642A1 (en) 2011-05-25
BRPI0910368B8 (pt) 2021-05-25
BRPI0910368B1 (pt) 2020-01-28
ITRM20080472A1 (it) 2010-02-28
MX358176B (es) 2018-08-08
CN102164592A (zh) 2011-08-24
WO2010023705A1 (en) 2010-03-04
EA201300272A1 (ru) 2013-07-30
IL211448A (en) 2016-05-31
AU2009286285A1 (en) 2010-03-04
PT2323642E (pt) 2014-05-15
DK2323642T3 (da) 2014-05-05
PL2323642T3 (pl) 2014-07-31
BRPI0910368A2 (pt) 2015-10-13
EA022055B1 (ru) 2015-10-30
US20110152219A1 (en) 2011-06-23
KR20110046567A (ko) 2011-05-04
PE20110287A1 (es) 2011-05-15
IL211448A0 (en) 2011-05-31
ES2460578T3 (es) 2014-05-13

Similar Documents

Publication Publication Date Title
CL2011000378A1 (es) Uso de edta asociado a trometamina o sales de edta oftalmologicamente aceptables asociadas a trometamina, y/o uno o mas fotointensificadores escogidos entre; amarillo de acridina, amarillo de quinidina, azul de metileno, eritrosina; composicion oftalmologica.
CO2021014292A2 (es) Moduladores de la vía de respuesta integrada al estrés
Ayaki et al. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells
JP2012500844A5 (es)
AR062046A1 (es) Soluciones oftalmicas
UY29348A1 (es) Inhibición de objetivos oculares mediada por arni
AR073990A1 (es) Derivados de fenilamida y piridilamida
AR060959A1 (es) Correccion de aberraciones de alto orden en lentes intraoculares
PE20190174A1 (es) Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
CR9678A (es) 7- aza-indazoles sustituidos , composiciones que los contienen, procedimiento de fabricacion y utilizacion
UY29802A1 (es) Análogos de la feniletilamina y su uso en el tratamiento del glaucoma
BR112015009228A8 (pt) Formulação farmacêutica líquida estéril e forma de dosagem intraocular oftálmica líquida estéril para injeção
BRPI0518169A (pt) tiazolil-dihidro-indazóis
BRPI1006732B8 (pt) lente dimensionada para uso num olho humano
RU2013142602A (ru) Композиции и способы для нехирургического лечения птоза
BR112012002098B8 (es)
UY36465A (es) Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico
AR074622A1 (es) Derivados de acido ciclopentanocarboxilico condensados sustituidos con acilamino y su uso como productos farmaceuticos
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112014005700A2 (pt) composições oftálmicas compreendendo derivados de prostaglandina f2 alfa e ácido hialurônico
PE20160526A1 (es) Composiciones oftalmologicas no irritantes de povidona-yodo
RU2012103538A (ru) Композиции и способы ингибирования пути jak
BRPI0710085B8 (pt) composições oftálmicas e seus kits
CL2020002252A1 (es) Formulación oftálmica.
GT200600277A (es) Derivados de prostaglandina